CompletedNCT04299321

Retrospective Natural History Study of Infants and Toddlers With LAMA2-CMD

Studying Congenital muscular dystrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Prothelia, Inc.
Principal Investigator
Carsten Bönnemann, MD
NINDS/NIH
Enrollment
75 enrolled
Eligibility
2-21 years · All sexes
Timeline
2020 – 2021

Study locations (1)

Collaborators

Cure CMD · The Bönnemann Laboratory, NINDS, National Institutes of Health · Children's Hospital of Philadelphia · Boston Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04299321 on ClinicalTrials.gov

Other trials for Congenital muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Congenital muscular dystrophy →

← Back to all trials